# Yoshiharu Uruno

> Yoshiharu Uruno is a Series A investor at JIC Venture Growth Investments backing Health Care. See 2 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [JIC Venture Growth Investments](https://shizune.co/investors/profile/jic-venture-growth-investments)
- Total investments: 2
- Last investment: Sep 2026
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/in/yoshiharu-uruno-9793ba228

Yoshiharu Uruno is a Series A investor at JIC Venture Growth Investments focused on Health Care and Biopharma. Mr. Yoshiharu Uruno is a Venture capitalist at JIC Venture Growth Investments

## Contacts

5 contacts available for Yoshiharu Uruno: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/mr-yoshiharu-uruno?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biopharma | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |
| Virtual Reality | 1 | 50% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SiccaNova Therapeutics | SiccaNova Therapeutics is a Japanese biopharmaceutical company dedicated to treating sicca (dryness) related medical conditions. The company’s lead drug candidate, XF8302, is a novel, small-molecule M3 muscarine receptor Positive Allosteric Modulator (M3 PAM). Developed initially for dry mouth in Sjögren’s syndrome patients, the drug enhancesnatural acetylcholine signaling to stimulate salivation without the systemic side effects common in traditional agonists. | $7.9M | Series A | Sep 03, 2026 | https://www.siccanova.com/ |
| BiPSEE | BiPSEE is a medical XR company that provides treatment support for children for the purpose of nurturing a sense of self-efficacy. They also deploy AR and VR animation with one button dentistry and medicine, whether outpatient or hospitalized in various situations your child's anxiety and pain relieve. It aims to reduce anxiety and pain inchildren in a wide range of medical fields such as dentistry, pediatrics, and dermatology.BiPSEE is abs ed in Tokyo, Japan. |  | Series A | Aug 17, 2026 | https://www.bipsee.co.jp/ |

2 of 2 investments shown.

## Co-investors
- [77 Partners](https://shizune.co/investors/profile/77-partners) — VC Fund, 1 deal together
- [Joyo Capital Partners](https://shizune.co/investors/profile/joyo-capital-partners) — VC Fund, 1 deal together
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 1 deal together
- [MPower Partners](https://shizune.co/investors/profile/mpower-partners) — VC Fund, 1 deal together
- [Red Capital](https://shizune.co/investors/profile/red-capital-f1a7) — VC Fund, 1 deal together
- [Tohoku University Venture Partners](https://shizune.co/investors/profile/tohoku-university-venture-partners) — VC Fund, 1 deal together

## About JIC Venture Growth Investments

VC Fund · Marunouchi, Japan

JIC-VGI helps promote innovation and improve its international competitiveness through growth-investments in startup companies. The firm accelerating innovation and helping to solve industrial and social issues by supporting and seeking innovative technologies and new businesses.JIC Venture Growth Investments was established in July 2020 and isbased in Tokyo, Japan.

2 contacts available at JIC Venture Growth Investments.

| Name | Title | Profile |
| --- | --- | --- |
| Hideki Yarimizu | CEO, President & Founder | https://shizune.co/investors/profile/hideki-shikizu |
| Yoshiharu Uruno | Venture capitalist | https://shizune.co/investors/profile/mr-yoshiharu-uruno |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Yoshiharu Uruno invest in?

Yoshiharu Uruno invests primarily in Health Care, Biopharma and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Yoshiharu Uruno?

Public channels for Yoshiharu Uruno include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Yoshiharu Uruno last invest?

The most recent investment recorded for Yoshiharu Uruno closed in Sep 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co